This report provides a comprehensive analysis of the global single-cell RNA sequencing (scRNA-seq) solution market, projecting significant growth through 2032. It examines key segments including equipment, services, and software, alongside diverse applications in cancer research, immunology, and precision medicine. Driven by advancements in genomic technology and declining sequencing costs, the study evaluates regional trends and competitive landscapes. Furthermore, it offers detailed insights into the strategies of leading industry players to identify emerging opportunities across research and clinical sectors.

Market Overview

The global Single Cell RNA Sequencing Solution market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate throughout the forecast period.

Single-cell RNA sequencing (scRNA-seq) is a cutting-edge technology that allows researchers to analyze the gene expression profiles of individual cells within a tissue or sample. The scRNA-seq solution comprises a combination of laboratory protocols, sequencing platforms, and computational tools specifically designed for the analysis of single-cell transcriptomes.

Market Dynamics

Growth Drivers & Trends

• Technological Revolution: The adoption of scRNA-seq technology has revolutionized the field of genomics and biomedical research, allowing researchers to gain unprecedented insights into cellular heterogeneity and gene expression at the single-cell level.
• Research Advancements: Continuous advancements in genomic research and the growing need for in-depth analysis of individual cells have driven the demand for scRNA-seq solutions.
• Diverse Applications: The technology has found applications in various fields, including cancer research, immunology, neuroscience, stem cell research, and precision medicine, further contributing to market growth.
• Future Growth Catalysts: The global market is expected to continue its rapid growth in the coming years, driven by technological advancements, improvements in data analysis tools, and the declining costs of sequencing. These factors are likely to drive wider adoption across research institutions and industries.
• Clinical & Omics Integration: The application of scRNA-seq in clinical settings and its potential integration with other omics technologies may further expand its market reach.

Report Scope & Methodology

Research Scope

LPI (LP Information)' newest research report, the “Single Cell RNA Sequencing Solution Industry Forecast,” reviews total world Single Cell RNA Sequencing Solution sales in 2025. It provides a comprehensive analysis by region and market sector of projected Single Cell RNA Sequencing Solution sales for 2026 through 2032. With Single Cell RNA Sequencing Solution sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis in US$ millions of the world Single Cell RNA Sequencing Solution industry.

Analytical Focus

This Insight Report provides a comprehensive analysis of the global Single Cell RNA Sequencing Solution landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyses the strategies of leading global companies with a focus on:

• Single Cell RNA Sequencing Solution portfolios and capabilities
• Market entry strategies
• Market positions
• Geographic footprints

Methodology

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook for Single Cell RNA Sequencing Solution. It breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a highly nuanced view of the current state and future trajectory of the global Single Cell RNA Sequencing Solution market.

Market Segmentation

By Type

• Equipment
• Service
• Software

By Application

• Research Institutions
• Bioscience Companies
• Others

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on inputs gathered from primary experts and an analysis of the companies' coverage, product portfolios, and market penetration:

• TAKARA BIO
• BioCat GmbH
• Thermo Fisher Scientific
• Roche Holding AG
• PerkinElmer
• Dolomite Bio
• Illumina
• Witec AG
• 10x Genomics, Inc
• Oxford Nanopore Technologies
• QIAGEN
• LC Sciences
• Pacific Biosciences
• Scipio bioscience
• CD Genomics

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Single Cell RNA Sequencing Solution Market Size (2021-2032)

    • 2.1.2 Single Cell RNA Sequencing Solution Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Single Cell RNA Sequencing Solution by Country/Region (2021, 2025 & 2032)

  • 2.2 Single Cell RNA Sequencing Solution Segment by Type

    • 2.2.1 Equipment

    • 2.2.2 Service

    • 2.2.3 Software

    • 2.2.4 Single Cell RNA Sequencing Solution Market Size by Type

      • 2.2.4.1 Single Cell RNA Sequencing Solution Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.4.2 Global Single Cell RNA Sequencing Solution Market Size Market Share by Type (2021-2026)

  • 2.3 Single Cell RNA Sequencing Solution Segment by Application

    • 2.3.1 Research Institutions

    • 2.3.2 Bioscience Companies

    • 2.3.3 Others

    • 2.3.4 Single Cell RNA Sequencing Solution Market Size by Application

      • 2.3.4.1 Single Cell RNA Sequencing Solution Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.4.2 Global Single Cell RNA Sequencing Solution Market Size Market Share by Application (2021-2026)

• 3 Single Cell RNA Sequencing Solution Market Size by Player

  • 3.1 Single Cell RNA Sequencing Solution Market Size Market Share by Player

    • 3.1.1 Global Single Cell RNA Sequencing Solution Revenue by Player (2021-2026)

    • 3.1.2 Global Single Cell RNA Sequencing Solution Revenue Market Share by Player (2021-2026)

  • 3.2 Global Single Cell RNA Sequencing Solution Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Single Cell RNA Sequencing Solution by Region

  • 4.1 Single Cell RNA Sequencing Solution Market Size by Region (2021-2026)

  • 4.2 Global Single Cell RNA Sequencing Solution Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Single Cell RNA Sequencing Solution Market Size Growth (2021-2026)

  • 4.4 APAC Single Cell RNA Sequencing Solution Market Size Growth (2021-2026)

  • 4.5 Europe Single Cell RNA Sequencing Solution Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Single Cell RNA Sequencing Solution Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Single Cell RNA Sequencing Solution Market Size by Country (2021-2026)

  • 5.2 Americas Single Cell RNA Sequencing Solution Market Size by Type (2021-2026)

  • 5.3 Americas Single Cell RNA Sequencing Solution Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Single Cell RNA Sequencing Solution Market Size by Region (2021-2026)

  • 6.2 APAC Single Cell RNA Sequencing Solution Market Size by Type (2021-2026)

  • 6.3 APAC Single Cell RNA Sequencing Solution Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Single Cell RNA Sequencing Solution Market Size by Country (2021-2026)

  • 7.2 Europe Single Cell RNA Sequencing Solution Market Size by Type (2021-2026)

  • 7.3 Europe Single Cell RNA Sequencing Solution Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Single Cell RNA Sequencing Solution by Region (2021-2026)

  • 8.2 Middle East & Africa Single Cell RNA Sequencing Solution Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Single Cell RNA Sequencing Solution Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Single Cell RNA Sequencing Solution Market Forecast

  • 10.1 Global Single Cell RNA Sequencing Solution Forecast by Region (2027-2032)

    • 10.1.1 Global Single Cell RNA Sequencing Solution Forecast by Region (2027-2032)

    • 10.1.2 Americas Single Cell RNA Sequencing Solution Forecast

    • 10.1.3 APAC Single Cell RNA Sequencing Solution Forecast

    • 10.1.4 Europe Single Cell RNA Sequencing Solution Forecast

    • 10.1.5 Middle East & Africa Single Cell RNA Sequencing Solution Forecast

  • 10.2 Americas Single Cell RNA Sequencing Solution Forecast by Country (2027-2032)

    • 10.2.1 United States Market Single Cell RNA Sequencing Solution Forecast

    • 10.2.2 Canada Market Single Cell RNA Sequencing Solution Forecast

    • 10.2.3 Mexico Market Single Cell RNA Sequencing Solution Forecast

    • 10.2.4 Brazil Market Single Cell RNA Sequencing Solution Forecast

  • 10.3 APAC Single Cell RNA Sequencing Solution Forecast by Region (2027-2032)

    • 10.3.1 China Single Cell RNA Sequencing Solution Market Forecast

    • 10.3.2 Japan Market Single Cell RNA Sequencing Solution Forecast

    • 10.3.3 Korea Market Single Cell RNA Sequencing Solution Forecast

    • 10.3.4 Southeast Asia Market Single Cell RNA Sequencing Solution Forecast

    • 10.3.5 India Market Single Cell RNA Sequencing Solution Forecast

    • 10.3.6 Australia Market Single Cell RNA Sequencing Solution Forecast

  • 10.4 Europe Single Cell RNA Sequencing Solution Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Single Cell RNA Sequencing Solution Forecast

    • 10.4.2 France Market Single Cell RNA Sequencing Solution Forecast

    • 10.4.3 UK Market Single Cell RNA Sequencing Solution Forecast

    • 10.4.4 Italy Market Single Cell RNA Sequencing Solution Forecast

    • 10.4.5 Russia Market Single Cell RNA Sequencing Solution Forecast

  • 10.5 Middle East & Africa Single Cell RNA Sequencing Solution Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Single Cell RNA Sequencing Solution Forecast

    • 10.5.2 South Africa Market Single Cell RNA Sequencing Solution Forecast

    • 10.5.3 Israel Market Single Cell RNA Sequencing Solution Forecast

    • 10.5.4 Turkey Market Single Cell RNA Sequencing Solution Forecast

  • 10.6 Global Single Cell RNA Sequencing Solution Forecast by Type (2027-2032)

  • 10.7 Global Single Cell RNA Sequencing Solution Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Single Cell RNA Sequencing Solution Forecast

• 11 Key Players Analysis

  • 11.1 TAKARA BIO

    • 11.1.1 TAKARA BIO Company Information

    • 11.1.2 TAKARA BIO Single Cell RNA Sequencing Solution Product Offered

    • 11.1.3 TAKARA BIO Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 TAKARA BIO Main Business Overview

    • 11.1.5 TAKARA BIO Latest Developments

  • 11.2 BioCat GmbH

    • 11.2.1 BioCat GmbH Company Information

    • 11.2.2 BioCat GmbH Single Cell RNA Sequencing Solution Product Offered

    • 11.2.3 BioCat GmbH Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 BioCat GmbH Main Business Overview

    • 11.2.5 BioCat GmbH Latest Developments

  • 11.3 Thermo Fisher Scientific

    • 11.3.1 Thermo Fisher Scientific Company Information

    • 11.3.2 Thermo Fisher Scientific Single Cell RNA Sequencing Solution Product Offered

    • 11.3.3 Thermo Fisher Scientific Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Thermo Fisher Scientific Main Business Overview

    • 11.3.5 Thermo Fisher Scientific Latest Developments

  • 11.4 Roche Holding AG

    • 11.4.1 Roche Holding AG Company Information

    • 11.4.2 Roche Holding AG Single Cell RNA Sequencing Solution Product Offered

    • 11.4.3 Roche Holding AG Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Roche Holding AG Main Business Overview

    • 11.4.5 Roche Holding AG Latest Developments

  • 11.5 PerkinElmer

    • 11.5.1 PerkinElmer Company Information

    • 11.5.2 PerkinElmer Single Cell RNA Sequencing Solution Product Offered

    • 11.5.3 PerkinElmer Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 PerkinElmer Main Business Overview

    • 11.5.5 PerkinElmer Latest Developments

  • 11.6 Dolomite Bio

    • 11.6.1 Dolomite Bio Company Information

    • 11.6.2 Dolomite Bio Single Cell RNA Sequencing Solution Product Offered

    • 11.6.3 Dolomite Bio Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Dolomite Bio Main Business Overview

    • 11.6.5 Dolomite Bio Latest Developments

  • 11.7 Illumina

    • 11.7.1 Illumina Company Information

    • 11.7.2 Illumina Single Cell RNA Sequencing Solution Product Offered

    • 11.7.3 Illumina Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Illumina Main Business Overview

    • 11.7.5 Illumina Latest Developments

  • 11.8 Witec AG

    • 11.8.1 Witec AG Company Information

    • 11.8.2 Witec AG Single Cell RNA Sequencing Solution Product Offered

    • 11.8.3 Witec AG Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Witec AG Main Business Overview

    • 11.8.5 Witec AG Latest Developments

  • 11.9 10x Genomics, Inc

    • 11.9.1 10x Genomics, Inc Company Information

    • 11.9.2 10x Genomics, Inc Single Cell RNA Sequencing Solution Product Offered

    • 11.9.3 10x Genomics, Inc Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 10x Genomics, Inc Main Business Overview

    • 11.9.5 10x Genomics, Inc Latest Developments

  • 11.10 Oxford Nanopore Technologies

    • 11.10.1 Oxford Nanopore Technologies Company Information

    • 11.10.2 Oxford Nanopore Technologies Single Cell RNA Sequencing Solution Product Offered

    • 11.10.3 Oxford Nanopore Technologies Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Oxford Nanopore Technologies Main Business Overview

    • 11.10.5 Oxford Nanopore Technologies Latest Developments

  • 11.11 QIAGEN

    • 11.11.1 QIAGEN Company Information

    • 11.11.2 QIAGEN Single Cell RNA Sequencing Solution Product Offered

    • 11.11.3 QIAGEN Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 QIAGEN Main Business Overview

    • 11.11.5 QIAGEN Latest Developments

  • 11.12 LC Sciences

    • 11.12.1 LC Sciences Company Information

    • 11.12.2 LC Sciences Single Cell RNA Sequencing Solution Product Offered

    • 11.12.3 LC Sciences Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 LC Sciences Main Business Overview

    • 11.12.5 LC Sciences Latest Developments

  • 11.13 Pacific Biosciences

    • 11.13.1 Pacific Biosciences Company Information

    • 11.13.2 Pacific Biosciences Single Cell RNA Sequencing Solution Product Offered

    • 11.13.3 Pacific Biosciences Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Pacific Biosciences Main Business Overview

    • 11.13.5 Pacific Biosciences Latest Developments

  • 11.14 Scipio bioscience

    • 11.14.1 Scipio bioscience Company Information

    • 11.14.2 Scipio bioscience Single Cell RNA Sequencing Solution Product Offered

    • 11.14.3 Scipio bioscience Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Scipio bioscience Main Business Overview

    • 11.14.5 Scipio bioscience Latest Developments

  • 11.15 CD Genomics

    • 11.15.1 CD Genomics Company Information

    • 11.15.2 CD Genomics Single Cell RNA Sequencing Solution Product Offered

    • 11.15.3 CD Genomics Single Cell RNA Sequencing Solution Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 CD Genomics Main Business Overview

    • 11.15.5 CD Genomics Latest Developments

• 12 Research Findings and Conclusion